[HTML][HTML] Liver fibrosis: therapeutic targets and advances in drug therapy
Z Tan, H Sun, T Xue, C Gan, H Liu, Y Xie… - Frontiers in cell and …, 2021 - frontiersin.org
Liver fibrosis is an abnormal wound repair response caused by a variety of chronic liver
injuries, which is characterized by over-deposition of diffuse extracellular matrix (ECM) and …
injuries, which is characterized by over-deposition of diffuse extracellular matrix (ECM) and …
[HTML][HTML] The prevalence of alcohol use disorders among people living with HIV/AIDS: a systematic review and meta-analysis
Background Alcohol use disorder (AUD) is common among people living with HIV/AIDS
(PLWHA) and associated with a greater risk of poor medication adherence, unsafe sexual …
(PLWHA) and associated with a greater risk of poor medication adherence, unsafe sexual …
[PDF][PDF] Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America recommendations for testing …
MG Ghany, TR Morgan… - …, 2020 - Wiley Online Library
HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …
[图书][B] WHO guidelines on hepatitis B and C testing
World Health Organization - 2017 - apps.who.int
Web Annexes Page 1 Page | i GUIDELINES ON HEPATITIS B AND C TESTING February 2017
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …
World scientists' warning to humanity: a second notice
Background. The objective of this study was to determine the efficacy of pegylated interferon
(peg-IFN) plus ribavirin (RBV) in human immunodeficiency virus (HIV)–infected patients with …
(peg-IFN) plus ribavirin (RBV) in human immunodeficiency virus (HIV)–infected patients with …
[图书][B] Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
World Health Organization - 2016 - apps.who.int
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
Consolidated Guidelines on HIV prevention, diagnosis, treatment and care for key populations …
Consolidated Guidelines on HIV prevention, diagnosis, treatment and care for key populations …
[PDF][PDF] Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
RK Sterling, E Lissen, N Clumeck, R Sola… - …, 2006 - Wiley Online Library
Liver biopsy remains the gold standard in the assessment of severity of liver disease.
Noninvasive tests have gained popularity to predict histology in view of the associated risks …
Noninvasive tests have gained popularity to predict histology in view of the associated risks …
[PDF][PDF] Diagnosis, management, and treatment of hepatitis C: an update
Background The hepatitis C virus (HCV) is a major public health problem and a leading
cause of chronic liver disease. 5 An estimated 180 million people are infected worldwide. 6 …
cause of chronic liver disease. 5 An estimated 180 million people are infected worldwide. 6 …
Mechanisms of hepatic fibrogenesis
SL Friedman - Gastroenterology, 2008 - Elsevier
Substantial improvements in the treatment of chronic liver disease have accelerated interest
in uncovering the mechanisms underlying hepatic fibrosis and its resolution. Activation of …
in uncovering the mechanisms underlying hepatic fibrosis and its resolution. Activation of …
Global epidemiology of hepatitis C virus infection
CW Shepard, L Finelli, MJ Alter - The Lancet infectious diseases, 2005 - thelancet.com
Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of
substantial morbidity and mortality in the future. The complexity and uncertainty related to …
substantial morbidity and mortality in the future. The complexity and uncertainty related to …